BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29417687)

  • 41. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
    Okano S; Enokida T; Onoe T; Ota Y; Motegi A; Zenda S; Akimoto T; Tahara M
    Int J Clin Oncol; 2019 Jul; 24(7):789-797. PubMed ID: 30796560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
    Tang WH; Sun W; Long GX
    Medicine (Baltimore); 2020 Sep; 99(36):e21785. PubMed ID: 32899005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
    Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J
    Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases.
    Lin SS; Massa ST; Varvares MA
    Head Neck; 2016 Feb; 38(2):208-15. PubMed ID: 25225171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.
    Porceddu SV; Bressel M; Poulsen MG; Stoneley A; Veness MJ; Kenny LM; Wratten C; Corry J; Cooper S; Fogarty GB; Collins M; Collins MK; Macann AMJ; Milross CG; Penniment MG; Liu HY; King MT; Panizza BJ; Rischin D
    J Clin Oncol; 2018 May; 36(13):1275-1283. PubMed ID: 29537906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
    Stokes WA; Amini A; Jones BL; McDermott JD; Raben D; Ghosh D; Goddard JA; Bowles DW; Karam SD
    Head Neck; 2017 Jun; 39(6):1113-1121. PubMed ID: 28301079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
    Noronha V; Joshi A; Patil VM; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; D'Cruz AK; Banavali S; Pai PS; Chaturvedi P; Chaukar D; Pande N; Chandrasekharan A; Talreja V; Vallathol DH; Mathrudev V; Manjrekar A; Maske K; Bhelekar AS; Nawale K; Kannan S; Gota V; Bhattacharjee A; Kane S; Juvekar SL; Prabhash K
    J Clin Oncol; 2018 Apr; 36(11):1064-1072. PubMed ID: 29220295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
    Waddle MR; Ma DJ; Visscher SL; Borah BJ; May JM; Price KA; Moore EJ; Patel SH; Hinni ML; Chintakuntlawar AV; Garcia JJ; Graner DE; Neben-Wittich MA; Garces YI; Hallemeier CL; Price DL; Kasperbauer JL; Janus JR; Foote RL; Miller RC
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):396-402. PubMed ID: 33359567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
    Yuan J; Shi K; Chen G; Xu W; Qiu L; Fei Y; Zhu Y; Wu M; Li Y; Sun X; Cao Y; Zhou S
    Cancer Control; 2024; 31():10732748241255535. PubMed ID: 38773761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
    Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion.
    Scherl C; Mantsopoulos K; Semrau S; Fietkau R; Kapsreiter M; Koch M; Traxdorf M; Grundtner P; Iro H
    Auris Nasus Larynx; 2017 Jun; 44(3):333-339. PubMed ID: 27569289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.